Submodule
Adrenoceptor Signaling and Organ Response
Adrenoceptors are G-protein-coupled receptors whose cellular pathways interact with baseline autonomic tone, reflexes, disease, concentration, and route.
- Alpha-1 Gq signaling
- Alpha-2 Gi signaling
- Beta-1 Gs signaling
- Beta-2 and beta-3 signaling
Smooth-muscle contraction
Release and central tone fall
Rate, force, renin
Relaxation and metabolic effects
Use alpha-1 to raise smooth-muscle calcium
Alpha-1 receptors primarily couple through Gq, phospholipase C, inositol trisphosphate, and intracellular calcium. Vascular activation contracts arteriolar and venous smooth muscle. Iris radial muscle, prostate, and bladder-neck responses reflect the same contractile program in different tissues.
Use alpha-2 to reduce transmitter release
Alpha-2 receptors primarily couple through Gi and reduce adenylyl cyclase activity. Presynaptic alpha-2 receptors can limit norepinephrine release, while central activation can lower sympathetic outflow. Postsynaptic vascular alpha-2 effects can contribute to vasoconstriction, especially at high local concentration.
Use beta-1 to increase cardiac and renin signaling
Beta-1 receptors couple predominantly through Gs, cAMP, and protein kinase A. Cardiac activation increases rate, conduction, relaxation, and contractility according to tissue and disease. Juxtaglomerular beta-1 activation increases renin release, linking acute receptor signaling to longer hormonal effects.
Use beta-2 and beta-3 in context
Beta-2 signaling relaxes airway, uterine, and selected vascular smooth muscle despite raising cAMP because protein kinase A reduces contractile machinery activity. Beta-2 also affects skeletal muscle, potassium distribution, and metabolism. Beta-3 activation contributes to bladder relaxation and adipose biology.
Quick check
Submodule
Direct and Indirect Sympathomimetics
Direct agonists bind adrenoceptors. Indirect agents increase synaptic catecholamines through release, transporter inhibition, or altered metabolism, making neuronal stores and interacting drugs part of their mechanism.
- Epinephrine and norepinephrine
- Dopamine and dobutamine
- Transmitter release and reuptake
- Tachyphylaxis and interaction risk
Dose and route reshape response
Vascular tone with reflex effects
Unpredictable renal benefit
Requires neuronal stores
Compare endogenous catecholamines
Epinephrine activates alpha-1, alpha-2, beta-1, and beta-2 receptors, with the observed pattern changing by concentration and route. Norepinephrine strongly activates alpha receptors and beta-1 with less beta-2 effect. Dopamine engages dopaminergic and adrenergic receptors across concentrations, but the bedside response is not reliably separated into neat dose zones.
Use dobutamine for a flow problem
Dobutamine is a synthetic catecholamine with prominent beta-1-mediated inotropic action and additional receptor effects from its stereoisomeric mixture. It can increase cardiac output but may lower resistance, cause tachyarrhythmia, or worsen myocardial oxygen imbalance. Hemodynamics determine whether it fits.
Understand indirect dependence
Releasing agents depend on neuronal catecholamine stores and vesicular handling, while transporter inhibitors increase transmitter persistence. Cocaine, amphetamine-like agents, and mixed sympathomimetics therefore interact with monoamine oxidase inhibition, tricyclic antidepressants, other stimulants, and depleted neuronal stores differently from a pure direct agonist.
Recognize rapid loss of response
Repeated exposure to some indirect sympathomimetics can deplete releasable transmitter or desensitize signaling, producing tachyphylaxis. Increasing dose can then add toxicity without restoring predictable benefit. Reassess mechanism and exposure rather than automatically escalating.
Quick check
Submodule
Vasopressors and Inotropes
Vasoactive therapy should correct a defined perfusion problem. Mean pressure, cardiac output, resistance, preload, rhythm, oxygen delivery, and the cause of shock must be interpreted together.
- Epinephrine and norepinephrine
- Phenylephrine
- Dobutamine and dopamine
- Infusion safety and perfusion monitoring
Target depends on perfusion
Afterload and ischemia risk
Arrhythmia and oxygen demand
Line, tissue, lactate, urine
Use epinephrine first for anaphylaxis
Intramuscular epinephrine is the critical first-line medicine for anaphylaxis because alpha and beta effects address vascular leak, airway edema, bronchospasm, and cardiovascular collapse. Auto-injector concentration, dose, site, technique, repeat assessment, and immediate emergency care follow the current product and emergency protocol.
Use norepinephrine for vascular tone with monitoring
Norepinephrine raises vascular resistance through alpha receptors while beta-1 activity can support cardiac function. It is titrated by trained clinicians for acute hypotension according to the current label and shock protocol. Correct severe hypovolemia when possible and monitor perfusion rather than pressure alone.
Use phenylephrine when pure alpha-1 action fits
Phenylephrine increases arterial and venous tone with little direct beta activity. Reflex bradycardia and increased afterload can reduce cardiac output in susceptible patients. It may fit selected vasodilatory states or procedural settings but can worsen a low-flow problem.
Protect the line and tissue
Catecholamine infusions require concentration verification, compatible access, pump safeguards, frequent site assessment, and a protocol for extravasation. Monitor rhythm, pressure, mental status, skin, urine output, lactate trend, peripheral perfusion, cardiac output when available, and ischemic symptoms.
Quick check
Submodule
Beta-2 Agonist Therapy
Inhaled beta-2 agonists prioritize airway smooth-muscle relaxation, but device technique, disease control, dose, selectivity, and systemic spillover determine benefit and risk.
- Albuterol and levalbuterol
- Short- and long-acting roles
- Device technique
- Tremor, tachycardia, lactate, and potassium
Technique controls dose
Airway smooth muscle relaxes
Tremor, tachycardia, hypokalemia
Signals unstable disease
Use inhaled albuterol for reversible bronchospasm
Albuterol is a relatively selective beta-2 agonist used for treatment or prevention of bronchospasm and prevention of exercise-induced bronchospasm in labeled populations. Metered-dose, dry-powder, and nebulized products have product-specific preparation, dose, and technique.
Distinguish rescue from maintenance
Short-acting beta-2 agonists provide rapid symptom relief. Long-acting beta-2 agonists have maintenance roles defined by disease and combination regimen. In asthma, long-acting therapy must follow current anti-inflammatory treatment guidance rather than being used as unopposed symptom suppression.
Expect systemic spillover at higher exposure
Tremor, tachycardia, palpitations, hypokalemia, hyperglycemia, and metabolic changes can accompany high or repeated beta-2 exposure. Severe airflow obstruction, repeated nebulization, coadministered stimulants, diuretics, and cardiac disease can magnify consequences.
Recognize paradoxical bronchospasm and treatment failure
A new or worsening bronchospasm immediately after inhalation can be paradoxical and requires product discontinuation and alternative treatment according to the label. A diminishing response or rapidly increasing rescue use requires urgent reassessment of technique, diagnosis, severity, and anti-inflammatory therapy.
Quick check
Submodule
Peripheral and Central Alpha Agonists
Alpha agonists can constrict peripheral vessels, reduce central sympathetic outflow, lower intraocular pressure, or alter nasal and ocular blood flow. Route and compartment determine which effect dominates.
- Phenylephrine and midodrine
- Clonidine and guanfacine
- Dexmedetomidine
- Topical decongestants and rebound
Vasoconstriction and reflex slowing
Standing pressure with supine risk
Sympathetic outflow falls
Monitored sedation
Use midodrine around upright function
Midodrine is converted to an active alpha-1 agonist that raises vascular tone for symptomatic orthostatic hypotension in selected patients. Benefit should be demonstrated in activities that matter. Supine hypertension, urinary retention, piloerection, paresthesia, and dose timing require current label guidance.
Use central alpha-2 agonists with withdrawal planning
Clonidine and guanfacine reduce sympathetic outflow through central alpha-2 mechanisms. Sedation, bradycardia, hypotension, dry mouth, and interaction with other depressant or rate-slowing drugs require monitoring. Abrupt discontinuation can produce rebound sympathetic activity and severe hypertension.
Use dexmedetomidine only in monitored settings
Dexmedetomidine is a central alpha-2 agonist used for labeled sedation under monitored care. Bradycardia and hypotension are common concerns, while transient hypertension can occur with loading or high peripheral concentrations. Airway and hemodynamic monitoring remain essential despite a distinct respiratory profile.
Limit topical vasoconstrictor overuse
Topical nasal alpha agonists can reduce congestion by vasoconstriction, but repeated use can produce rebound congestion and local injury. Ophthalmic agonists have product-specific indications and risks. Systemic absorption can matter in children, older adults, and cardiovascular disease.
Quick check
Submodule
Safety, Interactions, and Clinical Integration
Adrenergic toxicity is a mismatch between receptor effect and patient reserve. Cardiovascular, metabolic, ischemic, neurologic, and withdrawal risks must be interpreted across the full regimen.
- Arrhythmia and myocardial oxygen demand
- Excess vasoconstriction and extravasation
- Potassium, glucose, and lactate
- MAOI, tricyclic, stimulant, and beta-blocker interactions
Ischemia and arrhythmia
Digital, mesenteric, or extravasation injury
Dose and beta 2 burden
Central alpha 2 agents need planning
Balance pressure against flow and oxygen demand
Beta-1 stimulation can increase output but also rate, arrhythmia, and myocardial oxygen demand. Alpha-1 stimulation can restore vascular tone but increase afterload and regional ischemia. The desired hemodynamic endpoint is adequate organ perfusion with the lowest harmful exposure.
Respond quickly to extravasation
Vasopressor extravasation can produce intense local ischemia. Stop or relocate the infusion according to protocol, assess the site and distal perfusion, notify the appropriate team, and use current drug-specific extravasation management promptly. Prevention depends on access, concentration, pump, and frequent visualization.
Interpret metabolic findings in context
Beta-2 agonism can shift potassium into cells and increase glucose and lactate production. Hypokalemia, tremor, and tachycardia may reflect exposure, while elevated lactate can complicate interpretation of respiratory distress. Do not assume every lactate elevation means worsening tissue hypoxia.
Audit interacting sympathetic pathways
Monoamine oxidase inhibitors, tricyclic antidepressants, stimulants, cocaine, thyroid excess, and other sympathomimetics can amplify responses. Beta blockers can blunt beta-2 rescue and alter epinephrine physiology. Interaction significance depends on selectivity, dose, timing, and patient disease.
Quick check
Module test
Check the connections.
Each attempt draws 10 questions from the complete 100 question bank.
Each attempt draws a fresh set and rearranges the answer choices.
References
Current clinical foundation.
Lecture material was synthesized with the following contemporary guidance. Verify local policy and current guidance before applying clinical information.